The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation

Background Although several studies have documented adverse outcomes for vancomycin‐resistant Enterococcus (VRE) colonization and infection in allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients, data are inadequate for patients undergoing autologous (auto‐)HSCT. Methods We con...

Full description

Saved in:
Bibliographic Details
Published inTransplant infectious disease Vol. 17; no. 5; pp. 688 - 694
Main Authors Ford, C.D., Lopansri, B.K., Gazdik, M.A., Snow, G.L., Webb, B.J., Konopa, K.L., Petersen, F.B.
Format Journal Article
LanguageEnglish
Published Denmark Blackwell Publishing Ltd 01.10.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Although several studies have documented adverse outcomes for vancomycin‐resistant Enterococcus (VRE) colonization and infection in allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients, data are inadequate for patients undergoing autologous (auto‐)HSCT. Methods We conducted a retrospective cohort study of 300 consecutive patients receiving an auto‐HSCT between 2006 and 2014. Patients had stool cultures for VRE on admission and weekly during hospitalization. Results Thirty‐six percent of patients had VRE gastrointestinal (GI) colonization and 3% developed a VRE bloodstream infection (BSI), all of whom were colonized. VRE strain typing of BSI isolates showed that some patients shared identical patterns. Rates of colonization and BSI in colonized patients were similar to simultaneous patients undergoing allo‐HSCT, except that the latter had a higher rate of colonization at admission. A diagnosis of lymphoma was associated with an increased risk of colonization. VRE BSI was associated with longer lengths of stay and possibly higher costs, but no decrease in overall survival, and colonized patients had no VRE infections during the year following discharge. Repeat stool cultures in patients subsequently undergoing allo‐HSCT suggested that most, if not all, VRE‐positive auto‐HSCT patients lose their detectable GI colonization within a few months of discharge. Conclusion VRE colonization is frequent but carries a low risk for infection in patients undergoing auto‐HSCT. However, these patients can serve as reservoirs for transmission to higher risk patients. Moreover, patients may remain colonized if proceeding to an allo‐HSCT shortly after auto‐HSCT, potentially increasing the risk of the allogeneic procedure.
Bibliography:ArticleID:TID12433
ark:/67375/WNG-3KM008P1-T
Intermountain Healthcare Medical and Research Foundation
istex:E9ED26D651592EA2138E2DD448C55E90D660BF19
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1398-2273
1399-3062
DOI:10.1111/tid.12433